Cancer Center Update

February 15, 2005

Cancer Center Update is sent to Cancer Center members and staff every Tuesday at 10 a.m. To submit an item for publication, send the information to Sandi Sherman by noon the Friday before publication.

In This Issue:

Today's Cancer Center Seminar

News

Events

Professional Education and Seminars

Grant Information & Announcements

Reminders

NEWS

TODAY’S CANCER CENTER SEMINAR

Transforming growth factor a mammary tumorigenesis in transgenic mice
Teresa Rose-Hellekant, Ph.D., Assistant Professor, Department of Physiology, University of Minnesota, Duluth

A peek at next week’s seminar:

Hepatitis C Infection after Childhood Cancer

Melissa M. Hudson, M.D., Department of Hematology-Oncology, Director, After Completion of Therapy Clinic, St. Jude Children's Research Hospital, Memphis, TN

For a complete schedule visit: http://www.cancer.umn.edu/page/aboutus/date.html

SPECIAL SEMINAR

Thursday, February 17, 2005, 12:00 Noon, 2-101 BSBE
Sponsored by the Department of Genetics, Cell Biology, and Development and The Masonic Cancer Center

The Role of the Histone H3 Variant CENP-A in the Epigenetic Specification of Centromeres

Ben E. Black, Ph.D., Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, California. (Dr. Black is a Cancer Genetics Faculty Search Candidate)

FOURTH ANNUAL COLORECTAL CANCER SUMMIT

The Fourth Annual Colorectal Cancer Summit, hosted in part by the Minnesota Colorectal Cancer Consortium, is taking place on Friday, March 4th, at Mayo Clinic in Rochester as part of an event entitled "Cancer Prevention in Clinical Practice," This program will be held in Phillips Hall, Siebens Medical Education Building, at the Mayo Clinic in Rochester, MN from 7:30 a.m. to 4:00 p.m. The program will focus on:

Interactive discussions of clinical relevant topics related to cancer prevention
Strategies for overcoming practice barriers to screening
Cancer genetics and genomics

Information on these activities and more can be found at www.mcrfmn.org or by calling Cindy Iverson at 651-312-1556.

REMINDER: DON'T MISS THE CANCER AND THE HUMAN BODY EVENT ON SATURDAY

Bring your family and friends to the Cancer and the Human Body event, 1-4 p.m., Saturday at the Science Museum, 120 W. Kellogg Blvd. It's an opportunity to learn more about cancer and the research work being done at the cancer center. The event is free with museum admission of $8.50 for adults and $6.50 for children and seniors.

MARK YOUR CALENDARS!

The 7th KS95 for Kids Radiothon will take place March 4-6, 2005 at Ridgedale Mall. Be sure to tune in or stop by to show your support! Please contact Mary Schultze for additional information at 626-2961 or schul032@umn.edu.

GRANT ANNOUNCEMENTS

Please call Kamala Upadhyaya at 626-5326 for assistance with your application.

EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS (NOT-CA-05-014)

The Cancer Therapy Evaluation Program (CTEP), of the Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), is seeking, on a contract basis, organizations or consortiums with the capabilities and facilities to provide a resource for the conduct of Phase 2 and early clinical trials of NCI-sponsored agents, to evaluate biologic effects of these agents on their molecular targets, to evaluate other relevant biologic effects, and to determine clinically relevant outcomes/correlates.
http://grants.nih.gov/grants/guide/notice-files/NOT-CA-05-014.html

ADDENDUM — SMALL GRANTS PROGRAM FOR CANCER EPIDEMIOLOGY (PAR-04-159) (NOT-CA-05-015)

This addendum is to inform potential applicants of a discrepancy in Program Announcements PAR-04-159. This discrepancy involves the number of amendments to be accepted. The NIH has adopted a policy that limits the number of amendments to two.
http://grants.nih.gov/grants/guide/notice-files/NOT-CA-05-015.html

UNITS FOR HIV/AIDS CLINICAL TRIALS NETWORKS (RFA-AI-05-002)

Application Receipt Date(s): July 11, 2005

The objective of this RFA is to solicit applications for Clinical Trials Units (CTUs) to implement the clinical research plans of one or more of the HIV/AIDS Clinical Trials Networks. Each CTU will be led by a Principal Investigator, comprised of an Administrative Component and one or more Clinical Research Sites, and optimally configured to conduct clinical research by recruiting, screening, enrolling and following research participants from the populations most affected and/or endangered by the HIV/AIDS epidemic.
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-002.html

RESEARCH ON SLEEP AND SLEEP DISORDERS (PA-05-046)

Application Receipt Date(s): Multiple dates, see announcement.

As summarized in the 2003 National Sleep Disorders Research Plan ( http://www.nhlbi.nih.gov/health/prof/sleep/res_plan/index.html), multiple scientific areas in sleep and sleep disorders need additional research. This PA will use the NIH R01and R21 award mechanisms.
http://grants.nih.gov/grants/guide/pa-files/PA-05-046.html

PROTEIN BIOMARKERS OF INFECTION-ASSOCIATED CANCERS (PA-05-048)

Application Receipt Date(s): Multiple dates, see announcement.

This announcement invites new research proposals focused on identifying protein biomarkers for cancers where etiology of the disease is attributed to infectious agents. Applications for R01 and R21 awards will be considered.
http://grants.nih.gov/grants/guide/pa-files/PA-05-048.html

EDUCATION AND SEMINARS

CARCINOGENESIS AND CHEMOPREVENTION PROGRAM MONTHLY MEETING
Thursday, February 17, 2005, 4:15 p.m., 450 CCRB
DNA-DNA and DNA-Protein Cross-Linking by 1,2,3,4-Diepoxybutane
Natalia Tretyakova, Ph.D., Department of Medicinal Chemistry and The Masonic Cancer Center University of Minnesota

For a complete schedule visit http://www.cancer.umn.edu/page/aboutus/coreseminar.html

CANCER BIOLOGY RESEARCH CLUB

The Cancer Biology Research Club will not be meeting because of the following seminar:

February 18, 2005
MICaB Recruiting Seminar , 2-101 BSBE, 4:00 p.m.

Is innate immunity important for the pathogenesis of sexually transmitted HIV?

Michelle Irvin, Haase Lab

For a complete schedule visit http://www.cancer.umn.edu/page/grant7.html

BMT CONFERENCE

Monday, February 21, 2005, 1:15-2:15, 450 CCRB

Harnessing BMT to Cure Human Cancer
Xianzheng Zhou, M.D., Ph.D., Assistant Professor, Pediatric Blood and Marrow Transplant, University of Minnesota

For a complete schedule visit http://www.cancer.umn.edu/page/aboutus/bmtlect.html